Russia is the European country which has experienced a significant growth in clinical trials. In order to comply with international standards of clinical research, a Russian language version of ICH-GCP guidelines has been established in Russian clinical trials since 1999.
- realistic start-up time: 5 – 5.5 months
With a population of 143 million people (over 16 million in both Moscow and St Petersburg), Russia’s role in clinical research is due largely to successful recruitment. In fact, patient recruitment in Russia is reportedly ten times faster than in the US.
There are relatively few family doctors, patients generally go directly to hospital specialists for treatment – recruiting patients into clinical trials is much easier.
A large number of pediatric trials have been conducted over the last years in Russia. Around 20% of its population is represented by children under 16 years old (compared to Western Europe, where around 15% of the population is represented by children). The centralized system of pediatric healthcare, with a high concentration of children in academic pediatric centers and specialized children hospitals, creates an ideal environment for recruitment into clinical trials.
Estimated deaths per 100,000 population by cause (higher than world/European average):
|Diseases||Russia||World Average||Europe Average|
|Mental and substance use disorders||37.4||4.3||11.1|
Data from World Health Organization
It is estimated that 65% of the male population and 20% of the female population smoke every day in Russia. High rates of smoking contribute to a wide range of health problems, including lung cancer, COPD, and other disorders resulting in a high number of potential patients for research. Also alcohol consumption is very high in Russia, which leads to the highest burden of diseases such as: liver cirrhosis, injuries, ischemic heart disease, certain cancers, addiction, and depression.
Investigators and Sites
Main types of medical facilities are general hospitals and specialized clinics (located in all major towns and cities), polyclinics and first-aid stations offering medical care to the people in the rural areas.
With over 11,000 public hospitals, 21,000 outpatient clinics and 614,000 physicians, The Russian Federation presents the largest potential for clinical trials in Europe. It has one of the highest densities of hospital beds in the region: 97 beds/10,000 population (for comparison, there are 83 hospital beds per 10 000 population in Germany).
The private medical sector is present only in the large cities and it is accessible to a very low number of people.
Russian investigators are ICH GCP experienced, well educated, motivated and deliver very high recruitment and quality data.
Most of our staff have medical background.